Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative- and Cost-effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women Living With HIV to Full Viral Suppression

NCT06408350 is registered in ClinicalTrials.gov with Friends Research Institute, Inc. as lead sponsor.

NCT NCT06408350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06408350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative- and Cost-effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women Living With HIV to Full Viral Suppression
Lead sponsor
Friends Research Institute, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
April 11, 2024
Completion date
March 19, 2025
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv